The News
Catch the latest updates as CTMC drives innovation in cell therapy to accelerate development and manufacturing
to impact patients sooner
Press Releases
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Recent News
FDA Greenlights Lifileucel for Unresectable, Metastatic Melanoma Via Accelerated Approval
Article Link: https://www.cgtlive.com/view/fda-lifileucel-amtagvi-unresectable-metastatic-melanoma-accelerated-approval
BioSpace: FDA Approves First One-time Cell Therapy for a Solid Tumor
Article Link: https://www.biospace.com/article/an-fda-approval-for-iovance-could-jumpstart-40-year-old-field-/
Empowered Patient Podcast with Karen Jagoda
Special guests: Dr. Christopher Flowers, MD Anderson Cancer Center and Dr. Jason Bock, CTMC Article Link:...
Investing in a manufacturing infrastructure to harness tumour-infiltrating lymphocytes (TILs) for cancer treatment
Article Link:...
Tumor Infiltrating Lymphocytes (TILs): Old news or the next big thing in cell therapy?
Article Link: https://www.htworld.co.uk/insight/opinion/tumor-infiltrating-lymphocytes-tils-old-news-or-the-next-big-thing-in-cell-therapy-em22/
Slice of Healthcare: BioBreakthroughs / Podcast with CTMC CEO, Jason Bock
Article Link: https://sliceofhealthcare.com/11-jason-bock-ceo-at-ctmc/
Innovation Map: Podcast with Jason Bock, CEO, CTMC
Article Link: https://audioboom.com/posts/8293883-episode-185-scaling-life-saving-medicine-jason-bock-of-ctmc
Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T cell therapy
Article Link:...
Ori Biotech taps MD Anderson, National Resilience joint venture to put its automated cell and gene therapy manufacturing tech to the test
Article Link: https://www.fiercepharma.com/manufacturing/ori-biotech-taps-md-anderson-national-resilience-jv-put-its-automated-cell-and-gene